CD8


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
11 05 2021
Historique:
received: 22 01 2021
revised: 26 02 2021
accepted: 09 04 2021
pubmed: 5 5 2021
medline: 22 5 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

Efforts are being made worldwide to understand the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 (COVID-19) pandemic, including the impact of T cell immunity and cross-recognition with seasonal coronaviruses. Screening of SARS-CoV-2 peptide pools revealed that the nucleocapsid (N) protein induced an immunodominant response in HLA-B7

Identifiants

pubmed: 33945786
pii: S1074-7613(21)00168-0
doi: 10.1016/j.immuni.2021.04.006
pmc: PMC8043652
pii:
doi:

Substances chimiques

Coronavirus Nucleocapsid Proteins 0
Epitopes, T-Lymphocyte 0
HLA-B7 Antigen 0
Immunodominant Epitopes 0
Peptides 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1065.e5

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Immunity. 2020 Nov 17;53(5):1095-1107.e3
pubmed: 33128877
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
Retrovirology. 2015 Feb 20;12:20
pubmed: 25808313
J Immunol. 2016 Apr 15;196(8):3276-86
pubmed: 26983786
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W503-8
pubmed: 18503082
Blood. 2011 Aug 25;118(8):2138-49
pubmed: 21734237
J Immunol. 2009 Jul 1;183(1):430-7
pubmed: 19542454
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Hum Immunol. 2008 Jul;69(7):443-64
pubmed: 18638659
Immunity. 2021 Jan 12;54(1):14-18
pubmed: 33406391
Nat Commun. 2018 Dec 21;9(1):5427
pubmed: 30575715
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Hum Immunol. 2000 Mar;61(3):334-40
pubmed: 10689125
Clin Transl Immunology. 2020 Dec 07;9(12):e1219
pubmed: 33312565
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
Nat Commun. 2018 Mar 12;9(1):1026
pubmed: 29531227
Blood. 2009 Aug 20;114(8):1553-62
pubmed: 19542300
Sci Transl Med. 2012 Apr 4;4(128):128ra42
pubmed: 22491952
Sci Immunol. 2020 Nov 18;5(53):
pubmed: 33208380
J Immunol. 2020 Sep 15;205(6):1524-1534
pubmed: 32817371
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Sci Rep. 2014 Feb 10;4:3993
pubmed: 24509977
iScience. 2021 Feb 19;24(2):102096
pubmed: 33521593
Immunogenetics. 1999 Nov;50(3-4):201-12
pubmed: 10602880
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24384-24391
pubmed: 32913053
Cell. 2020 Oct 1;183(1):13-15
pubmed: 32976799
J Immunol. 2012 Mar 15;188(6):2742-8
pubmed: 22323539
J Synchrotron Radiat. 2018 May 1;25(Pt 3):885-891
pubmed: 29714201
Nat Med. 2021 Jan;27(1):78-85
pubmed: 33184509
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Cold Spring Harb Protoc. 2011 Jun 01;2011(6):695-715
pubmed: 21632778
Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788
pubmed: 31722398
Nat Rev Immunol. 2020 Aug;20(8):457-458
pubmed: 32636479
Nat Med. 1997 Feb;3(2):212-7
pubmed: 9018241
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12599-604
pubmed: 20616031
J Immunol. 2018 Jun 15;200(12):3993-4003
pubmed: 29735483
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Immunity. 2020 Dec 15;53(6):1245-1257.e5
pubmed: 33326767

Auteurs

Katie E Lineburg (KE)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Emma J Grant (EJ)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Srividhya Swaminathan (S)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia.

Demetra S M Chatzileontiadou (DSM)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Christopher Szeto (C)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Hannah Sloane (H)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Archana Panikkar (A)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Jyothy Raju (J)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Pauline Crooks (P)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Sweera Rehan (S)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Andrea T Nguyen (AT)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Lea Lekieffre (L)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Michelle A Neller (MA)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Zhen Wei Marcus Tong (ZWM)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.

Dhilshan Jayasinghe (D)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Keng Yih Chew (KY)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.

Christian A Lobos (CA)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Hanim Halim (H)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.

Jacqueline M Burrows (JM)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Alan Riboldi-Tunnicliffe (A)

Australian Synchrotron, ANSTO, Clayton, VIC 3168, Australia.

Weisan Chen (W)

Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia.

Lloyd D'Orsogna (L)

Department of Clinical Immunology, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA 6150, Australia; School of Medicine, University of Western Australia, Nedlands, WA 6009, Australia.

Rajiv Khanna (R)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia.

Kirsty R Short (KR)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia; Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, QLD 4072, Australia.

Corey Smith (C)

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia. Electronic address: corey.smith@qimrberghofer.edu.au.

Stephanie Gras (S)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia. Electronic address: s.gras@latrobe.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH